Business Trends– category –
-
U.S. Department of Energy Launches $3 Million Perovskite Startup Prize to Accelerate Commercialization
Department of Energy USA Overview The U.S. Department of Energy (DOE) has announced a $3 million two-phase 'American-Made Challenges: Perovskite Startup Prize' to accelerate the development and manufacturing of perovskite solar cells. Th... -
Mitsubishi Electric & Sony Semiconductor Solutions Form Joint Venture ‘Advanced Vision Solutions’ to Drive Labor-Saving, Unmanned Manufacturing with AI Vision Sensors
Mitsubishi Electric (News Release) Japan Overview Mitsubishi Electric and Sony Semiconductor Solutions have agreed to establish a joint venture, "Advanced Vision Solutions Co., Ltd.," by October 2026, aiming to deliver AI vision sensor s... -
Trinity Biotech and Latch Medical Forge Alliance for AI-Powered Precision Intradermal Drug Delivery in Metabolic Disorders
GlobeNewswire (via Trinity Biotech plc) Ireland Overview Trinity Biotech has announced a strategic partnership with Latch Medical, integrating Trinity's AI-native CGM+ wearable biosensor platform with Latch Medical's innovative intraderm... -
AI-Native Biosensors Fuel Precision Drug Delivery: Trinity Biotech and Latch Medical Target Diabetes, Obesity
GlobeNewswire (Trinity Biotech) Ireland Overview Trinity Biotech and Latch Medical have formed a strategic partnership to revolutionize diabetes and obesity treatment. The collaboration integrates Trinity Biotech's AI-native CGM+ wearabl... -
mRNA-LNP Technology Proven Effective in COVID-19 Vaccines, Bolstering Drug Delivery Customization Capabilities
Inside Therapeutics USA Overview This article discusses the revolutionary potential of mRNA-lipid nanoparticles (LNPs) in pharmaceuticals, vaccines, and therapeutics. LNPs are highlighted as the most clinically advanced platform for mRNA... -
Roche Discontinues Lupus TCE Development, Retains Strong Interest in Autoimmune Cell Therapy
Fierce Biotech Switzerland Overview Roche has halted the development of its T-cell engager (TCE) for systemic lupus erythematosus (lupus) but affirmed its strategic commitment to cell therapy for autoimmune diseases. This decision signal... -
Instinct Bio Debuts on Nasdaq Following SPAC Merger, Infusing New Capital into Cell and Gene Therapy Sector
GlobeNewswire USA Overview Instinct Bio has completed its business combination with Relativity Acquisition Corp., a Special Purpose Acquisition Company (SPAC), and will commence trading on Nasdaq under the ticker "BIOT" on July 24, 2026.... -
Long-Term Safety of iPS Cell Therapy for Spinal Cord Injury Confirmed in Japan
Nippon.com Japan Overview Long-term safety has been confirmed in Japan for a spinal cord injury treatment involving the transplantation of neural progenitor cells derived from induced pluripotent stem cells (iPS cells). A clinical trial ... -
Qatar Issues Stark Warning Against Unapproved Injectable Exosomes, Citing Lack of Scientific Basis and Safety Data
ILoveQatar.net Qatar Overview The Qatar Ministry of Public Health has issued a strong public warning against the use of unapproved injectable exosome products for both medical and cosmetic applications. The Ministry explicitly stated tha... -
Crystalys Therapeutics Secures $35M Series A Funding to Advance Gene Therapy Development
BioBucks USA Overview Crystalys Therapeutics, a gene therapy developer, has raised $35 million in a Series A funding round. This capital will accelerate the research and development of its innovative gene therapy pipeline, targeting unme...
